ArticleInternational journal of surgery case reports2025
SeptAlign™ biosorbable implant for correction of mobile cartilaginous nasal septum deviation: A case report.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety and Effectiveness of a Bioabsorbable Septal Implant for Cartilaginous Nasal Septal Deviation.Laryngoscope investigative otolaryngology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The standard of care for symptomatic nasal septal deviation in adults, refractory to medical management, is septoplasty. SeptAlign™ is a minimally-invasive, bioabsorbable implant cleared by the United States Food and Drug Administration for mechanical correction of minor nasal septal deviation and a novel alternative to traditional septoplasty. Presentation of case: We present a case report of a 42 year old male with a history of symptomatic nasal septal deviation and nasal airway obstruction who strongly wished to avoid open surgical correction. Discussion: We successfully implanted the SeptAlign device to correct the cartilaginous deviation with severe anterior caudal deflection. We present pre- and post-procedure computed tomography and endoscopy imaging and patient reported outcomes to demonstrate correction of nasal airway obstruction and symptoms. Conclusion: SeptAlign is a less invasive alternative to traditional septoplasty or septorhinoplasty in patients with cartilaginous nasal septal deviation, with the added benefits of avoiding general anesthesia and the convenience of an in-office procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.